United States
Securities and Exchange Commission
Washington, D.C. 20549
|
||||||||||||||||
Form 15
|
||||||||||||||||
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTION 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
||||||||||||||||
Commission File Number:
|
1-31771
|
|||||||||||||||
MEDLINK INTERNATIONAL, INC.
|
||||||||||||||||
(Exact name of registrant as specified in its charter)
|
||||||||||||||||
150 Motor Parkway, Suite 401
Hauppauge, NY 11788
(631) 342-8800
|
||||||||||||||||
(Address, including zip code, and telephone number, including are code, of registrant’s principal executive offices)
|
||||||||||||||||
Class A Common Stock, par value $0.001 per share
Class B Common Stock, par value $0.001 per share
Preferred Stock, par value $0.001 per share
|
||||||||||||||||
(Title of each class of securities covered by this Form)
|
||||||||||||||||
None
|
||||||||||||||||
(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)
|
||||||||||||||||
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
||||||||||||||||
Rule 12g-4(a)(1)
|
||||||||||||||||
Rule 12g-4(a)(2)
|
X
|
|||||||||||||||
Rule 12h-3(b)(1)(i)
|
||||||||||||||||
Rule 12h-3(b)(1)(ii)
|
||||||||||||||||
Rule 15d-6
|
||||||||||||||||
Approximate number of holders of record as of the certification or notice date:
|
||||||||||||||||
Class A Common Stock, par value $0.001 per share:
|
Three hundred and twenty four (324) holders
|
|||||||||||||||
Class B Common Stock, par value $0.001 per share:
|
One (1) holder
|
|||||||||||||||
Preferred Stock, par value $0.001 per share:
|
Two (2) holders
|
|||||||||||||||
Date:
|
March 26, 2012
|
By:
|
/s/ Ray Vuono
|
Ray Vuono, President
|